Danforth Technology Company

Danforth Technology Company (DTC) is a wholly owned subsidiary of the Donald Danforth Plant Science Center, established in 2022 and based in St. Louis, Missouri. It facilitates early-stage development of agtech startups built on technologies discovered by Danforth Center scientists. Beyond seed funding, DTC provides intellectual property development, licensing, entrepreneurship support, and early management, connecting Danforth Center researchers with entrepreneurs, investors, companies, and technology leaders to commercialize plant science discoveries. Its sector focus is agricultural technology, particularly crop genetics, genome editing, and plant-based biological solutions. Startups it has launched include Peptyde Bio (antimicrobial peptides), Metablify (metabolite detection platform), and Spearhead Bio (genome-editing technology), building on earlier Danforth-linked successes like Benson Hill, which went public via SPAC. DTC's investment approach centers on translating lab-based scientific breakthroughs into commercially viable companies, providing seed capital and interim leadership. Its criteria favor Danforth Center-originated technologies with clear paths to addressing food security, agriculture, and environmental challenges.